Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.46 |
| ▸ | KDM4A | O75164 | 1/20 | 0.46 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.46 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.46 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.45 |
| ▸ | FABP3 | P05413 | 5/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28556457 | 1.00 | CA1 (0.62) | CA1NFKB1KDM4CKDM4APHF8 | |
| SCHEMBL4868756 | 0.98 | CA1 (0.65) | CA1NFKB1KDM4CKDM4APHF8 | |
| SCHEMBL5592664 | 0.95 | CA1 (0.62) | CA1NFKB1KDM4CKDM4APHF8 | |
| SCHEMBL20894203 | 0.95 | CA1 (0.62) | CA1NFKB1KDM4CKDM4APHF8 | |
| SCHEMBL5590801 | 0.95 | CA1 (0.62) | CA1NFKB1KDM4CKDM4APHF8 | |
| Potassium Ion SCHEMBL25191979 | 0.95 | CA1 (0.62) | CA1NFKB1KDM4CKDM4APHF8 | |
| Potassium Ion SCHEMBL11652127 | 0.95 | CA1 (0.62) | CA1NFKB1KDM4CKDM4APHF8 | |
| SCHEMBL1925994 | 0.95 | CA1 (0.62) | CA1NFKB1KDM4CKDM4APHF8 | |
| SCHEMBL11241226 | 0.95 | CA1 (0.62) | CA1NFKB1KDM4CKDM4APHF8 | |
| SCHEMBL8378952 | 0.95 | CA1 (0.67) | CA1NFKB1KDM4CKDM4APHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3474953-B1 | SUBSTANCE MIXTURE CONTAINING GLYCOSAMINOGLYCAN, METHOD FOR PRODUCING SAME AND USE OF SAME | FACH DR CHRISTIAN (DE) | 2022-11-16 | — | — | EP | claimed |
| EP-3474953-A1 | SUBSTANCE MIXTURE CONTAINING GLYCOSAMINOGLYCAN, METHOD FOR PRODUCING SAME AND USE OF SAME | Fach, Dr. Christian (DE) | 2019-05-01 | — | — | EP | claimed |
| WO-2017220796-A1 | SUBSTANCE MIXTURE CONTAINING GLYCOSAMINOGLYCAN, METHOD FOR PRODUCING SAME AND USE OF SAME | FACH DR CHRISTIAN (DE) | 2017-12-28 | — | — | WO | claimed |
| EP-2934476-A2 | STYLING AGENTS FOR STYLING KERATIN-CONTAINING FIBRES WHICH CAN BE RESTYLED | Henkel AG&Co. KGAA (DE) | 2015-10-28 | — | — | EP | claimed |
| WO-2014095194-A2 | STYLING AGENTS FOR STYLING KERATIN-CONTAINING FIBRES WHICH CAN BE RESTYLED | HENKEL AG & CO. KGAA (DE) | 2014-06-26 | — | — | WO | claimed |
| EP-3805327-B1 | ANTIFOULING PAINT COMPOSITION | MITSUBISHI CHEM CORP (JP) | 2026-04-15 | — | — | EP | disclosed |
| US-20250213438-A1 | BENTON GEL ACTIVATOR COMPOSITION | SHISEIDO COMPANY, LTD. (JP) | 2025-07-03 | — | — | US | disclosed |
| EP-4556074-A1 | OIL-IN-WATER EMULSION COMPOSITION | Shiseido Company, Ltd. (JP) | 2025-05-21 | — | — | EP | disclosed |
| US-20250152489-A1 | COSMETIC COMPOSITION | SHISEIDO COMPANY , LTD. (JP) | 2025-05-15 | — | — | US | disclosed |
| CN-119855580-A | Powder cosmetic | 株式会社资生堂 | 2025-04-18 | — | — | CN | disclosed |
| US-20250049654-A1 | COSMETIC COMPOSITION | SHISEIDO COMPANY, LTD. (JP) | 2025-02-13 | — | — | US | disclosed |
| EP-4499029-A1 | BENTON GEL ACTIVATOR COMPOSITION | Shiseido Company, Ltd. (JP) | 2025-02-05 | — | — | EP | disclosed |
| WO-2003015910-A1 | MICROCAPSULE DISPERSION | BASF AKTIENGESELLSCHAFT (DE) | 2003-02-27 | — | — | WO | disclosed |
| WO-2002072047-A2 | COSMETIC OR PHARMACEUTICAL AGENT | BASF AKTIENGESELLSCHAFT (DE) | 2002-09-19 | — | — | WO | disclosed |
| EP-1191041-A2 | Aqueous polymer dispersions containing colorants | BASF AKTIENGESELLSCHAFT (DE) | 2002-03-27 | — | — | EP | disclosed |
| WO-2002015865-A2 | SKIN COSMETIC FORMULATIONS | BASF AKTIENGESELLSCHAFT (DE) | 2002-02-28 | — | — | WO | disclosed |
| EP-1132078-A2 | Cosmetical or dermatological sunscreens | BASF AKTIENGESELLSCHAFT (DE) | 2001-09-12 | — | — | EP | disclosed |
| EP-1116484-A2 | Treatment of a cosmetic with NIR-rays and its use | BASF AKTIENGESELLSCHAFT (DE) | 2001-07-18 | — | — | EP | disclosed |
| EP-1092416-A2 | Use of free-flowing polymers PF incorporating dyes as colouring components in cosmetics | BASF AKTIENGESELLSCHAFT (DE) | 2001-04-18 | — | — | EP | disclosed |
| EP-1064924-A2 | Use of cross-linked cationic polymers in skin cosmetic compositions and in dermatological compositions | BASF AKTIENGESELLSCHAFT (DE) | 2001-01-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250049654-A1 | COSMETIC COMPOSITION | CUTA, DSG1, GLA | CA1 4456/4885NFKB1 2895/4885KDM4C 3765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.